ORITAVANCIN vs OSPEMIFENE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ORITAVANCIN vs OSPEMIFENE: Safety Overview
| Metric | ORITAVANCIN | OSPEMIFENE |
|---|---|---|
| Total FAERS Reports | 884 | 2,047 |
| Deaths Reported | 29 | 2 |
| Death Rate | 3.3% | 0.1% |
| Hospitalizations | 157 | 60 |
| Average Patient Age | 55.9 yrs | 61.7 yrs |
| % Female Patients | 52.2% | 99.8% |
| FDA Approval Date | N/A | Feb 13, 2024 |
| Manufacturer | Melinta Therapeutics, LLC | Duchesnay USA, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Prescription |